ArticleJAAD international2025

Prognostic markers could extend adjuvant immunotherapy to high-risk stage IB/IIA melanoma: A modeling study.

Samuel X Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.